These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5010378)

  • 21. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

  • 22. [Special diagnostic problems in individual cases of foreign workers demonstrated on a case of leprosy].
    Asshauer E
    Offentl Gesundheitsdienst; 1965 Nov; 27(11):452-5. PubMed ID: 5887039
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 25. Length of continued treatment of an inactive case of leprosy.
    Dharmendra
    Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
    Privat Y; Faye I; Bellossi A
    Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transition of leprous occular changes under chemotherapy].
    Arai M
    Keisei Geka; 1967 Apr; 10(2):Suppl:7-9. PubMed ID: 6070441
    [No Abstract]   [Full Text] [Related]  

  • 28. Acedapsone in leprosy treatment: trial in 68 active cases in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):48-52. PubMed ID: 4672994
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of action of sulfones.
    Bergel M
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):89-90. PubMed ID: 7195883
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lights and shadows in the treatment of leprosy].
    Bertaccini G
    G Ital Dermatol Minerva Dermatol; 1966; 107(5):437-46. PubMed ID: 4869129
    [No Abstract]   [Full Text] [Related]  

  • 31. Follow up study of thirty-six borderline cases of leprosy.
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):103-4. PubMed ID: 5616299
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of modern therapy of leprosy].
    Schuppli R
    Hautarzt; 1969 Mar; 20(3):116-8. PubMed ID: 5355958
    [No Abstract]   [Full Text] [Related]  

  • 33. [Eye manifestations of leprosy].
    Dolezalová V
    Cesk Oftalmol; 1973 Sep; 29(5):388-92. PubMed ID: 4742940
    [No Abstract]   [Full Text] [Related]  

  • 34. [The main anti-leprosy drugs, their respective costs and refunding by Social Security].
    Merklen FP
    Bull Acad Natl Med; 1968 Apr; 152(13):220-2. PubMed ID: 4913494
    [No Abstract]   [Full Text] [Related]  

  • 35. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014
    [No Abstract]   [Full Text] [Related]  

  • 36. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
    Magora A; Sheskin J; Sagher F; Gonen B
    Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of leprosy with diucifon].
    Goloshchapov NM; Steklovskiĭ VK; Filipskikh TP; Khromova EB
    Vestn Dermatol Venerol; 1983 Apr; (4):67-71. PubMed ID: 6868818
    [No Abstract]   [Full Text] [Related]  

  • 38. [Findings of the real value of sulphonotherapy in the programs of prevention of leprosy].
    Lima Lde S
    Rev Bras Leprol; 1968-1969; 36(1):31-6. PubMed ID: 5748409
    [No Abstract]   [Full Text] [Related]  

  • 39. How can adherence with multi-drug therapy in leprosy be improved?
    Williams MC
    Lepr Rev; 2005 Jun; 76(2):160-1. PubMed ID: 16038249
    [No Abstract]   [Full Text] [Related]  

  • 40. [Late evolutive recurrences of formerly treated leprosy].
    Merklen FP; Cottenot F; Pennec J; Blanchet P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):459-61. PubMed ID: 5170176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.